Applications
-
WB
-
IHC-P
-
ICC
REACTIVITY
-
Human
-
Rat
SPECIFICATIONS
Product Type
Mouse monoclonal primary
Product Name
BLCAP Mouse Monoclonal Antibody [4E1] (M1701-10)
Immunogen
Peptide
Host
Mouse
Positive Control
HepG2, rat cervix tissue, human breast tissue.
Conjugation
Unconjugated
Clonality
Monoclonal
Clone Number
4E1
PROPERTIES
Form
Liquid
Storage Condition
Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
2 ug/ul
PURIFICATION
Protein G purified.
Isotype
IgG2a
APPLICATION DILUTION
-
WB
-
1:1,000-1:2,000
-
ICC
-
1:50-1:200
-
IHC-P
-
1:50-1:200
TARGET
UNIPROT #
PROTEIN NAME
BLCAP
SYNONYMS
Bc10 antibody; Bladder cancer 10 kDa protein antibody; Bladder cancer related protein (10kD) antibody; Bladder cancer-associated protein antibody; BLCAP antibody; BLCAP_HUMAN antibody
SEQUENCE SIMILARITIES
Belongs to the BLCAP family.
TISSUE SPECIFICITY
Ubiquitous. Expressed in cervical tissues. Down-regulated in bladder invasive carcinoma, renal cell carcinoma and in primary cervical carcinoma.
SUBCELLULAR LOCATION
Membrane.
FUNCTION
BLCAP is a highly conversed gene with two exons and an intron encoding a 10kDa protein, which was originally identified from invasive bladder carcinoma in 2002. BLCAP is subject to adenosine to inosine (A-to-I) RNA editing. A-to-I RNA editing is an important post-transcription modification of RNA sequence, generating a diversity of RNA products different from the original DNA sequence. The adenosine deaminase acting on double-stranded RNA (ADAR) family of enzymes catalyze the conversion of adenosine (A) to inosine (I) in the double stranded RNA, and inosine is finally recognized as guanosine (G) in the process of mRNA translation. May regulate cell proliferation and coordinate apoptosis and cell cycle progression via a novel mechanism independent of both p53/TP53 and NF-kappa-B.